- Exchange: Toronto
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Paladin Labs Inc
+ Add to WatchlistPLB:CN
48.5200 CAD 0.7200 1.51%As of 15:59:37 ET on 05/21/2013.
Snapshot for Paladin Labs Inc (PLB)
| Open: | 47.7600 | Day's Range: | 47.7600 - 49.0000 | Volume: | 24,415 |
|---|---|---|---|---|---|
| Previous Close: | 47.8000 | 52wk Range: | 39.0100 - 51.8900 | 1-Yr Rtn: | +15.50% |
Key Statistics for PLB
| Current P/E Ratio (ttm) | 16.8472 |
|---|---|
| Estimated P/E(12/2013) | 21.6317 |
| Relative P/E vs. SPTSX | 1.0304 |
| Earnings Per Share (CAD) (ttm) | 2.8800 |
| Est. EPS (CAD) (12/2013) | 2.2430 |
| Est. PEG Ratio | 0.4326 |
| Market Cap (M CAD) | 997.88 |
| Shares Outstanding (M) | 20.57 |
| 30 Day Average Volume | 15,113 |
| Price/Book (mrq) | 2.5161 |
| Price/Sale (ttm) | 4.1141 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/02/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for PLB
Company Profile & Key Executives for PLB
Paladin Labs, Inc. develops, markets, and distributes pharmaceuticals. The Company offers a variety of products in urology, dermatology, rheumatology, and other specialty markets.
| Jonathan Ross GoodmanChairman/CEO/Co-Founder | Mark A BeaudetInterim President & CEO |
| Samira SakhiaChief Financial Officer | Mark H NawackiExec VP:Corporate & Product Dev |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
PLB News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page